| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/25/2007 | US20070020274 Method of preventing or reducing the likelihood of pregnancy |
| 01/25/2007 | US20070020272 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use thereof |
| 01/25/2007 | US20070020271 Endothelial cell specific antibodies and uses thereof |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/25/2007 | US20070020267 monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 01/25/2007 | US20070020266 Gpr54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020264 Serum albumin binding peptides for tumor targeting |
| 01/25/2007 | US20070020263 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 01/25/2007 | US20070020262 Uses of mammalian cytokine: related reagents |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070020259 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases |
| 01/25/2007 | US20070020258 Immunoglobulin variants |
| 01/25/2007 | US20070020257 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 01/25/2007 | US20070020256 Methods for treatment of allergic asthma |
| 01/25/2007 | US20070020255 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 01/25/2007 | US20070020233 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease |
| 01/25/2007 | US20070020179 Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof |
| 01/25/2007 | CA2854576A1 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | CA2657953A1 Alpha-synuclein antibodies and methods related thereto |
| 01/25/2007 | CA2616256A1 Genetically modified antibody composition |
| 01/25/2007 | CA2616021A1 Methods to express recombinant proteins from lentiviral vectors |
| 01/25/2007 | CA2616005A1 Beta-glucuronide-linker drug conjugates |
| 01/25/2007 | CA2615744A1 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | CA2615485A1 Modified antibody fragments |
| 01/25/2007 | CA2615386A1 Catalytic immunoglobulins |
| 01/25/2007 | CA2614972A1 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | CA2610237A1 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands |
| 01/25/2007 | CA2578613A1 Binding domain fusion proteins |
| 01/24/2007 | EP1746421A2 Diagnostic and therapeutic application of antibodies against the urokinase receptor |
| 01/24/2007 | EP1746162A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/24/2007 | EP1746160A2 Hepatocyte growth factor receptor antagonists and uses thereof |
| 01/24/2007 | EP1746157A1 Method of proliferating plasma cell |
| 01/24/2007 | EP1746107A2 Antibody variants and fragments thereof |
| 01/24/2007 | EP1746106A2 Use of TACI as an anti-tumor agent |
| 01/24/2007 | EP1745799A2 Compositions and methods of treating tumors |
| 01/24/2007 | EP1745297A1 Use of precursors of enkephalins and/or their fragments in medical diagnostics |
| 01/24/2007 | EP1745289A2 Methods and antibodies for nitrofuran detection |
| 01/24/2007 | EP1745288A2 Assay for antibodies |
| 01/24/2007 | EP1745129A2 Canine pancreatic lipse |
| 01/24/2007 | EP1745077A2 Monoclonal antibody sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent |
| 01/24/2007 | EP1745076A2 Antibodies specific for glycoprotein vi and methods of producing these antibodies |
| 01/24/2007 | EP1745075A2 Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof |
| 01/24/2007 | EP1745072A2 Method for producing soluble mhc proteins |
| 01/24/2007 | EP1745067A2 Polypeptides from non-typeable haemophilus influenzae |
| 01/24/2007 | EP1744734A2 Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds |
| 01/24/2007 | EP1744620A2 Novel gene disruptions, compositions and methods relating thereto |
| 01/24/2007 | EP1481007B1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom |
| 01/24/2007 | EP1374901B1 Graft rejection suppressors |
| 01/24/2007 | EP1330552B1 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 01/24/2007 | EP1276501B9 Method for treatment of tumors using photodynamic therapy |
| 01/24/2007 | EP1265920B9 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 01/24/2007 | EP1257285B1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/24/2007 | EP1180525B1 Transcriptional activation inhibitory protein |
| 01/24/2007 | EP1116792B1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 01/24/2007 | EP1056845B1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 01/24/2007 | EP1032674B1 (chlamydia pneumoniae) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/24/2007 | EP1003777B1 PGC-1, A NOVEL BROWN FAT PPARgamma COACTIVATOR |
| 01/24/2007 | EP0970213B1 Death domain containing receptor 5 |
| 01/24/2007 | EP0946727B1 Antibody mutants |
| 01/24/2007 | EP0941341B1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 01/24/2007 | EP0941244B1 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide and a method of detecting auto-immune antibodies |
| 01/24/2007 | EP0843961B1 Chimeric animal and method for constructing the same |
| 01/24/2007 | EP0758383B1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 01/24/2007 | EP0749321B1 Active immunization using a siderophore receptor protein |
| 01/24/2007 | EP0546091B1 Homologous recombination in mammalian cells |
| 01/24/2007 | CN1902313A Wt1-origin HLA-DR-binding antigen peptide |
| 01/24/2007 | CN1902231A CD20 antibodies with increased Fc receptor binding affinity and effector function |
| 01/24/2007 | CN1902230A Anti-SARS virus antibody, hybridoma producing the antibody and immunoassay reagent using the antibody |
| 01/24/2007 | CN1902229A IL-18 binding proteins |
| 01/24/2007 | CN1902228A Monkey immunoglobulin sequences |
| 01/24/2007 | CN1902227A TIM-3 ligands and methods thereof |
| 01/24/2007 | CN1901937A Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 01/24/2007 | CN1901936A Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 01/24/2007 | CN1901932A Cytokine antagonist molecules |
| 01/24/2007 | CN1901930A Integrin alphaiibbeta3 specific antibodies and peptides |
| 01/24/2007 | CN1900320A Diagnostic assay |
| 01/24/2007 | CN1900279A Polynucleotide for inducing apoptosis and its coded polypeptide and use |
| 01/24/2007 | CN1900116A Anti-lymphotoxin-beta receptor antibodies, pharmaceutical composition containing the same and pharmaceutical application thereof |
| 01/24/2007 | CN1900115A Method for preparing monoclonal antibody resisting O-type foot and mouth disease virus and antibody and use |
| 01/24/2007 | CN1900114A Method for removing beta-lactoglobulin in milk and extracting high purity immune globulin |
| 01/24/2007 | CN1900113A Tumor relative polypeptide and its coding gene sequence |
| 01/24/2007 | CN1900086A Process for preparing ethyl parathion artificial semi antigen, artificial antigen, antibody and their use |
| 01/24/2007 | CN1899308A Method for producing immunological milk containing specific antibody |
| 01/24/2007 | CN1296478C Cell culture medium |
| 01/24/2007 | CN1296386C Use of CD 25 binding molecules in steroid-resistant patients |
| 01/24/2007 | CN1296385C Monoclonal antibody for anti pig growth hormone, preparation process and application |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/23/2007 | US7166714 Polynucleotide encoding a STEAP-1 polypeptide, used for diagnosis and treatment of prostate cancer |
| 01/23/2007 | US7166712 A cDNA encoding a mammalian MDM2 binding protein for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein |
| 01/23/2007 | US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/23/2007 | US7166706 Use of ketol-acid reductoisomerase inhibitors to prevent or treat fungal infection of plants |
| 01/23/2007 | US7166705 Histamine receptor antibody |
| 01/23/2007 | US7166704 Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer |
| 01/23/2007 | US7166702 Used to treat inflammatory responses associated with activation, proliferation and migration of immune effector cells, including leukocyte cell types, neutrophils, macrophages, and eosinophils |
| 01/23/2007 | US7166701 Human survivin interacting protein 1 (SIP-1) |
| 01/23/2007 | US7166698 Mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 01/23/2007 | US7166697 V-like domain binding molecules |